7
White solid, 80% yield. mp 161–163 °C (CH Cl ); R 0.42
3079, 2922, 1594, 1505, 1477, 1442, 1405, 1223, 1209, 1186,
1100, 1033; HRMS (ESI) not found.
2
2
f
1
(
30% EtOAc in hexane) [KMnO /UV]; H NMR (400 MHz,
4
CDCl ) δ 9.19 (d, J = 2.4 Hz, 1H), 8.39 (dd, J = 2.4, 0.8 Hz, 1H),
3
8
.21–8.14 (m, 3H), 7.99–7.95 (m, 2H), 7.95–7.92 (m, 1H), 7.81
(
ddd, J = 8.4, 6.9, 1.5 Hz, 1H), 7.65 (ddd, J = 8.2, 6.9, 1.2 Hz,
4.7.8. 2',6'-Dimethyl-[1,1'-biphenyl]-4-sulfonyl fluoride (5g)
13
1
1
1
1
H); C { H} NMR (101 MHz, CDCl ) δ 149.1, 148.3, 145.5,
3
White solid, 67% yield. mp 133–134 °C (CHCl ); R 0.56
3 f
1
34.6, 132.5 (d, J = 25.4 Hz), 131.4, 130.7, 129.6, 129.5, 128.6,
(
10% EtOAc in hexane) [UV]; H NMR (400 MHz, CDCl ) δ
3
19
1
28.4, 127.8, 127.8; F { H} NMR (377 MHz, CDCl ) δ 66.5;
3
8.09 (dtd, J = 8.2, 2.0, 0.4 Hz, 2H), 7.44 (dtd, J = 8.6, 1.9,
0.9 Hz, 2H), 7.23 (dd, J = 8.4, 6.7 Hz, 1H), 7.16–7.13 (m, 2H),
-
1
+
IR νmax (neat)/cm 3606, 1595, 1403, 1216, 1097; LRMS (ESI )
m/z 288.0 ([M+H] ); HRMS (ESI ) m/z calc. for C H FNO S
[
+
+
+
13
1
15
11
2
2.01 (s, 6H); C { H} NMR (101 MHz, CDCl ) δ 149.6, 139.4,
3
+
M+H] 288.0489, found 288.0490.
1
35.4, 131.6 (d, J = 24.6 Hz), 130.8, 128.9, 128.3, 127.9, 20.9;
1
9
1
-1
F { H} NMR (377 MHz, CDCl ) δ 66.1; IR ν
(neat)/cm
3
max
3
088, 2966, 2923, 1590, 1464, 1403, 1208, 1179, 1163, 1092;
4
.7.4. tert-Butyl 4-(5-(4-(fluorosulfonyl)phenyl)pyridin-2-
HRMS (ESI) not found.
yl)piperazine-1-carboxylate (5c)
White solid, 80% yield. mp 198–200 °C (CHCl ); R 0.42
3
f
1
(
8
30% EtOAc in hexane) [UV]; H NMR (400 MHz, CDCl ) δ
4.7.9. 4'-Sulfamoyl-[1,1'-biphenyl]-4-sulfonyl fluoride (5h)
3
.49 (dd, J = 2.6, 0.7 Hz, 1H), 8.04 (dt, J = 8.5, 2.1 Hz, 2H), 7.77
White solid, 73% yield. mp 181–183 °C (EtOAc); R 0.14
f
1
(dd, J = 8.1, 1.9 Hz, 1H), 7.75–7.72 (m, 2H), 6.74 (dd, J = 9.0,
(
30% EtOAc in hexane) [UV]; H NMR (400 MHz, DMSO-d ) δ
6
0
.8 Hz, 1H), 3.69–3.60 (m, 4H), 3.61–3.50 (m, 4H), 1.49 (s, 9H);
8
.25 (d, J = 8.6 Hz, 2H), 8.14 (d, J = 8.1 Hz, 2H), 8.02–7.95 (m,
13
1
13 1
C { H} NMR (101 MHz, CDCl ) δ 159.3, 154.9, 147.0, 145.9,
3
4H), 7.49 (s, 2H); C { H} NMR (101 MHz, CDCl ) δ 146.4,
3
1
4
36.3, 130.6 (d, J = 24.8 Hz), 129.3, 126.8, 123.4, 107.0, 80.3,
1
44.6, 140.7, 130.9 (d, J = 23.9 Hz), 129.2, 128.9, 128.1, 126.5;
19
1
19
1
-1
4.9, 43.3 (br.), 28.6; F { H} NMR (377 MHz, CDCl ) δ 66.6;
3
F { H} NMR (377 MHz, CDCl ) δ 66.6; IR ν
(neat)/cm
max
−
3
-
1
IR νmax (neat)/cm 2981, 2923, 1673, 1605, 1589, 1424, 1403,
1
HRMS (ESI ) m/z calc. for C H FN O S [M+H] 422.1544,
found 422.1548.
3367, 3263, 1594, 1404, 1329, 1215, 1153, 1097; LRMS (ESI )
m/z 313.9 ([M−H] ); HRMS (ESI ) m/z calc. for C H FNO S
4 2
[M−H] 313.9963, found 313.9961.
+
+
−
−
−
243, 1212, 1190, 1172; LRMS (ESI ) m/z 422.0 ([M+H] );
12
9
+
+
+
−
20
25
3
4
4
.7.10. 4'-Ethoxy-3'-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-
4
.7.5. 4-(2-Acetylthiophen-3-yl)benzenesulfonyl fluoride (5d)
Off-white solid, 87% yield. mp 127–129 °C (CHCl ); R 0.44
pyrazolo[4,3-d]pyrimidin-5-yl)-[1,1'-biphenyl]-4-sulfonyl
fluoride (5i)
3
f
1
(30% EtOAc in hexane) [UV]; H NMR (400 MHz, CDCl ) δ
3
5-(5-Bromo-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-
H-pyrazolo[4,3-d]pyrimidin-7-one (39.1 mg, 0.10 mmol,
.0 equiv), 4-(fluorosulfonyl)phenylboronic acid 3a (31 mg,
8
7
.05 (dt, J = 8.5, 1.8 Hz, 2H), 7.66 (dtd, J = 8.8, 1.9, 0.8 Hz, 2H),
7
1
.61 (d, J = 5.1 Hz, 1H), 7.09 (d, J = 5.0 Hz, 1H), 2.39 (s, 3H);
13
1
C { H} NMR (101 MHz, CDCl ) δ 190.5, 144.3, 144.1, 138.9,
3
0.15 mmol, 1.5 equiv), Pd(OAc) (1.1 mg, 5.0 µmol, 5.0 mol%),
XPhos (4.8 mg, 10 µmol, 10 mol%), 1.0 M aq. K PO solution
(0.2 mL, 0.20 mmol, 2.0 equiv) and 1,4-dioxane (0.4 mL) were
used. Sulfonyl fluoride 5i was isolated as a white solid (29.0 mg),
62% yield. mp 176–178 °C (CHCl ); R 0.26 (50% EtOAc in
2
1
32.6 (d, J = 25.3 Hz), 131.9, 131.2, 130.7, 128.5, 29.9;
3
4
19
1
-1
F { H} NMR (377 MHz, CDCl ) δ 66.2; IR ν
(neat)/cm
+
3
max
3
2
105, 1672, 1402, 1274, 1209, 1186, 1095; LRMS (ESI ) m/z
85.0 ([M+H] ); HRMS (ESI ) m/z calc. for C H FO S
3 2
+
+
+
1
2
10
3
f
+
1
[
M+H] 285.0050, found 285.0051.
hexane) [KMnO /UV]; H NMR (400 MHz, CDCl ) δ 10.94 (s,
4
3
1
8
H), 8.67 (d, J = 2.5 Hz, 1H), 8.08–8.00 (m, 2H), 7.80 (dd, J =
.9, 0.8 Hz, 2H), 7.65 (dd, J = 8.6, 2.5 Hz, 1H), 7.11 (d, J =
4
.7.6. 4-(1-Methyl-1H-pyrazol-4-yl)benzenesulfonyl fluoride (5e)
White solid, 43% yield. mp 85–86 °C (CHCl ); R 0.29 (50%
8.7 Hz, 1H), 4.35–4.26 (m, 2H), 4.21 (s, 3H), 2.87 (dd, J = 8.0,
7.1 Hz, 2H), 1.80 (h, J = 7.4 Hz, 2H), 1.58 (t, J = 7.0 Hz, 3H),
0.96 (t, J = 7.4 Hz, 3H) (recorded as a mixture of tautomers at
3
f
1
EtOAc in hexane) [UV]; H NMR (400 MHz, CDCl ) δ 7.98 (dt,
J = 8.5, 1.9 Hz, 2H), 7.85 (d, J = 0.9 Hz, 1H), 7.75 (d, J = 0.8 Hz,
3
13
1
ratio of 82:13:5); C { H} NMR (101 MHz, CDCl ) δ 157.3,
3
1
H), 7.67 (dtd, J = 8.8, 2.1, 1.0 Hz, 2H), 3.99 (s, 3H);
153.9, 147.8, 147.4, 146.9, 138.6, 132.2, 131.5 (d, J = 24.7 Hz),
13
1
C { H} NMR (101 MHz, CDCl ) δ 140.5, 137.5, 130.0 (d, J =
131.2, 130.3, 129.3, 128.0, 124.7, 121.2, 113.9, 65.9, 38.4, 27.9,
3
1
9
1
19
1
2
4.3 Hz), 129.4, 128.3, 126.0, 121.1, 39.5; F { H} NMR
22.5, 14.8, 14.2; F { H} NMR (377 MHz, CDCl
3
) δ 66.5; IR
-
1
-1
(377 MHz, CDCl ) δ 66.5; IR νmax (neat)/cm 3101, 2948, 1597,
νmax (neat)/cm 3310, 2959, 2932, 1697, 1593, 1566, 1486, 1473,
1406, 1213, 1159, 1031; LRMS (ESI ) m/z 471.2 ([M+H] );
HRMS (ESI ) m/z calc. for C23
3
+
+
+
1
564, 1402, 1206, 1192, 1097; LRMS (ESI ) m/z 241.0
+
+
+
+
+
+
+
([M+H] ); HRMS (ESI ) m/z calc. for C H FN O S [M+H]
H24FN
4
O
4
S [M+H] 471.1497,
10
10
2
2
2
41.0442, found 241.0443.
found 471.1496.
4
.7.7. 4-(Benzo[d][1,3]dioxol-5-yl)benzenesulfonyl fluoride (5f)
White solid, 93% yield. mp 104–105 °C (CHCl ); R 0.45
4.7.11. 4'-(5-(p-Tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-[1,1'-
biphenyl]-4-sulfonyl fluoride (5j)
3
f
1
(20% EtOAc in hexane) [UV]; H NMR (400 MHz, CDCl ) δ
1-(4-Bromophenyl)-5-(p-tolyl)-3-(trifluoromethyl)-1H-
3
8
0
0
.03 (dtd, J = 8.8, 2.0, 0.5 Hz, 2H), 7.74 (dtd, J = 8.8, 2.1,
.9 Hz, 2H), 7.12 (dd, J = 8.0, 1.9 Hz, 1H), 7.09 (dd, J = 1.9,
pyrazole
4-(fluorosulfonyl)phenylboronic acid 3a (31 mg, 0.15 mmol,
1.5 equiv), Pd(OAc) (1.1 mg, 5.0 µmol, 5.0 mol%), XPhos
(4.8 mg, 10 µmol, 10 mol%), 1.0 M aq. K PO solution (0.2 mL,
(38.1 mg,
0.10 mmol,
1.0 equiv),
.4 Hz, 1H), 6.93 (d, J = 8.0 Hz, 1H), 6.05 (s, 2H);
2
13
1
C { H} NMR (101 MHz, CDCl ) δ 148.9, 148.8, 148.4, 132.8,
3
4
3
1
31.0 (d, J = 24.6 Hz), 129.1, 127.9, 121.7, 109.1, 107.8, 101.8;
0.20 mmol, 2.0 equiv) and 1,4-dioxane (0.4 mL) were used.
Sulfonyl fluoride 5j was isolated as an off-white solid (43.5 mg),
19
1
-1
F { H} NMR (377 MHz, CDCl ) δ 66.5; IR ν
(neat)/cm
3
max
9
5% yield. mp 121–123 °C (CHCl ); R 0.41 (10% EtOAc in
3 f